Lapatinib: A Viewpoint by Masakazu Toi

ISSN： 0012-6667

Source： Drugs, Vol.67, Iss.14, 2007-01, pp. : 2109-2110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lapatinib

By Dhillon Sohita Wagstaff Antona J.

Drugs, Vol. 67, Iss. 14, 2007-01 ,pp. : 2101-2108

Adis International

Access to resources Recommend Favorite

Lapatinib: Hyperbilirubinaemia: case report

Reactions Weekly, Vol. 1, Iss. 1431, 2012-01 ,pp. : 27-27

Adis International

Access to resources Recommend Favorite

Lapatinib and renal cell carcinoma

By Gross-Goupil Marine Bernhard Jean-Christophe Ravaud Alain

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 11, 2012-11 ,pp. : 1727-1732

Informa Healthcare

Access to resources Recommend Favorite

Lapatinib for breast cancer: a review of the current literature

By MacFarlane Robyn J Gelmon Karen A

Expert Opinion on Drug Safety, Vol. 10, Iss. 1, 2011-01 ,pp. : 109-121

Informa Healthcare

Access to resources Recommend Favorite

Lapatinib no help in HER-2-negative breast cancer

Inpharma, Vol. 1, Iss. 1663, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite